Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07231029
PHASE1

A Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment

Sponsor: Taisho Pharmaceutical Co., Ltd.

View on ClinicalTrials.gov

Summary

An open-label study to evaluate the effect of TS-172 administration on pharmacokinetics in patients with hepatic impairment

Official title: An Open-label Pharmacokinetic Study of TS-172 in Patients With Hepatic Impairment

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

24

Start Date

2025-12-23

Completion Date

2026-10-31

Last Updated

2026-01-09

Healthy Volunteers

No

Interventions

DRUG

TS-172

Single oral administration of TS-172 20mg

Locations (1)

Taisho Pharmaceutical Co., Ltd selected site

Tokyo, Japan